Standard

Лекарственные поражения печени (клинические рекомендации для врачей). / Ивашкин, В.Т.; Барановский, Андрей Юрьевич; Райхельсон, Карина Леонидовна; Пальгова, Людмила Константиновна; Маевская, М.В.; Кондрашина, Элина Александровна; Марченко, Наталья Валерьевна; Некрасова, П.; Никитин, И.Г.

в: РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ, Том 29, № 1, 2019, стр. 85-115.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Ивашкин, ВТ, Барановский, АЮ, Райхельсон, КЛ, Пальгова, ЛК, Маевская, МВ, Кондрашина, ЭА, Марченко, НВ, Некрасова, П & Никитин, ИГ 2019, 'Лекарственные поражения печени (клинические рекомендации для врачей)', РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ, Том. 29, № 1, стр. 85-115. https://doi.org/10.22416/1382-4376-2019-29-1-101-131

APA

Ивашкин, В. Т., Барановский, А. Ю., Райхельсон, К. Л., Пальгова, Л. К., Маевская, М. В., Кондрашина, Э. А., Марченко, Н. В., Некрасова, П., & Никитин, И. Г. (2019). Лекарственные поражения печени (клинические рекомендации для врачей). РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ, 29(1), 85-115. https://doi.org/10.22416/1382-4376-2019-29-1-101-131

Vancouver

Ивашкин ВТ, Барановский АЮ, Райхельсон КЛ, Пальгова ЛК, Маевская МВ, Кондрашина ЭА и пр. Лекарственные поражения печени (клинические рекомендации для врачей). РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ. 2019;29(1):85-115. https://doi.org/10.22416/1382-4376-2019-29-1-101-131

Author

BibTeX

@article{94117a04574a444c88d5f746bbf2a271,
title = "Лекарственные поражения печени (клинические рекомендации для врачей)",
abstract = " Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver injuries (DILI) are intended for all medical specialists, who treat such patients in their clinical practice. Key findings. The presented recommendations contain information about the epidemiological data, terminology, diagnostic principles, classification, prognosis and management of patients with DILI. The recommendations list pharmacological agents that most commonly cause DILI, including its fatal cases. Dose-dependent and predictable (hepatotoxic), as well as dose-independent and unpredictable (idiosyncratic) DILI forms are described in detail, which information has a particular practical significance. The criteria and types of DILI are described in detail, with the most reliable diagnostic and prognostic scales and indices being provided. The pathogenesis and risk factors for the development of DILI are considered. The clinical and morphological forms (phenotypes) of DILI are described. The diseases that are included into the differential diagnosis of DILI, as well as the principles of its implementation, are given. The role and significance of various diagnostic methods for examining a patient with suspected DILI is described, with the liver biopsy role being discussed. Clinical situations, in which DILI can acquire a chronic course, are described. A section on the assessment of causal relationships in the diagnosis of DILI is presented; the practical value of using the CIOMS-RUCAM scale is shown. All possible therapeutic measures and pharmacological approaches to the treatment of patients with various DILI phenotypes are investigated in detail. A particular attention is paid to the use of glucocorticosteroids in the treatment of DILI. Conclusion. The presented clinical recommendations are important for improving the quality of medical care in the field of hepatology. ",
author = "В.Т. Ивашкин and Барановский, {Андрей Юрьевич} and Райхельсон, {Карина Леонидовна} and Пальгова, {Людмила Константиновна} and М.В. Маевская and Кондрашина, {Элина Александровна} and Марченко, {Наталья Валерьевна} and П. Некрасова and И.Г. Никитин",
year = "2019",
doi = "10.22416/1382-4376-2019-29-1-101-131",
language = "русский",
volume = "29",
pages = "85--115",
journal = "РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ",
issn = "1382-4376",
publisher = "Гастро",
number = "1",

}

RIS

TY - JOUR

T1 - Лекарственные поражения печени (клинические рекомендации для врачей)

AU - Ивашкин, В.Т.

AU - Барановский, Андрей Юрьевич

AU - Райхельсон, Карина Леонидовна

AU - Пальгова, Людмила Константиновна

AU - Маевская, М.В.

AU - Кондрашина, Элина Александровна

AU - Марченко, Наталья Валерьевна

AU - Некрасова, П.

AU - Никитин, И.Г.

PY - 2019

Y1 - 2019

N2 - Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver injuries (DILI) are intended for all medical specialists, who treat such patients in their clinical practice. Key findings. The presented recommendations contain information about the epidemiological data, terminology, diagnostic principles, classification, prognosis and management of patients with DILI. The recommendations list pharmacological agents that most commonly cause DILI, including its fatal cases. Dose-dependent and predictable (hepatotoxic), as well as dose-independent and unpredictable (idiosyncratic) DILI forms are described in detail, which information has a particular practical significance. The criteria and types of DILI are described in detail, with the most reliable diagnostic and prognostic scales and indices being provided. The pathogenesis and risk factors for the development of DILI are considered. The clinical and morphological forms (phenotypes) of DILI are described. The diseases that are included into the differential diagnosis of DILI, as well as the principles of its implementation, are given. The role and significance of various diagnostic methods for examining a patient with suspected DILI is described, with the liver biopsy role being discussed. Clinical situations, in which DILI can acquire a chronic course, are described. A section on the assessment of causal relationships in the diagnosis of DILI is presented; the practical value of using the CIOMS-RUCAM scale is shown. All possible therapeutic measures and pharmacological approaches to the treatment of patients with various DILI phenotypes are investigated in detail. A particular attention is paid to the use of glucocorticosteroids in the treatment of DILI. Conclusion. The presented clinical recommendations are important for improving the quality of medical care in the field of hepatology.

AB - Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver injuries (DILI) are intended for all medical specialists, who treat such patients in their clinical practice. Key findings. The presented recommendations contain information about the epidemiological data, terminology, diagnostic principles, classification, prognosis and management of patients with DILI. The recommendations list pharmacological agents that most commonly cause DILI, including its fatal cases. Dose-dependent and predictable (hepatotoxic), as well as dose-independent and unpredictable (idiosyncratic) DILI forms are described in detail, which information has a particular practical significance. The criteria and types of DILI are described in detail, with the most reliable diagnostic and prognostic scales and indices being provided. The pathogenesis and risk factors for the development of DILI are considered. The clinical and morphological forms (phenotypes) of DILI are described. The diseases that are included into the differential diagnosis of DILI, as well as the principles of its implementation, are given. The role and significance of various diagnostic methods for examining a patient with suspected DILI is described, with the liver biopsy role being discussed. Clinical situations, in which DILI can acquire a chronic course, are described. A section on the assessment of causal relationships in the diagnosis of DILI is presented; the practical value of using the CIOMS-RUCAM scale is shown. All possible therapeutic measures and pharmacological approaches to the treatment of patients with various DILI phenotypes are investigated in detail. A particular attention is paid to the use of glucocorticosteroids in the treatment of DILI. Conclusion. The presented clinical recommendations are important for improving the quality of medical care in the field of hepatology.

UR - http://www.mendeley.com/research/druginduced-liver-injuries-clinical-guidelines-physicians

U2 - 10.22416/1382-4376-2019-29-1-101-131

DO - 10.22416/1382-4376-2019-29-1-101-131

M3 - статья

VL - 29

SP - 85

EP - 115

JO - РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ

JF - РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ

SN - 1382-4376

IS - 1

ER -

ID: 41113389